CLINICAL TRIALS PROFILE FOR TOLVAPTAN
✉ Email this page to a colleague
All Clinical Trials for tolvaptan
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00043758 ↗ | Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 2 | 2002-07-01 | The purpose of this study is to study the effects of tolvaptan on the size and function of the left heart chamber (ventricle) in patients with congestive heart failure (CHF) |
NCT00043771 ↗ | Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 2 | 2002-05-01 | Patients with congestive heart failure will be assessed for safety and clinical effects of Tolvaptan 30 mg every day versus 15 mg twice a day over a period of 7 days. |
NCT00071331 ↗ | EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | 2003-09-01 | The purpose of this study is to compare the effectiveness of tolvaptan or placebo in adults with worsening congestive heart failure (CHF). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for tolvaptan
Condition Name
Clinical Trial Locations for tolvaptan
Trials by Country
Clinical Trial Progress for tolvaptan
Clinical Trial Phase
Clinical Trial Sponsors for tolvaptan
Sponsor Name